OMNOVA Solutions Inc. (OMN)
(Delayed Data from NYSE)
$7.59 USD
+0.37 (5.12%)
Updated May 3, 2019 04:02 PM ET
After-Market: $7.59 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[OMN]
Reports for Purchase
Showing records 1 - 20 ( 167 total )
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Synthomer Acquires OMN for Pre Synergy LTM Adjusted EBITDA Multiple of 9.9x; Misses F2Q19 EPS Expectations
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Terminating Coverage Due to the Acquisition by Synthomer plc
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Specialty Chemicals Leading Indicators Through May 2019
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Industry: Chemical - Specialty
The 10th Specialty Chemical Conference - First Impressions
Provider: G.RESEARCH, LLC
Analyst: MORBELLI R
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Fiscal 1Q19 EPS Loss of $0.06 Was Below Consensus; Company Expects Positive EPS Growth in FY19
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Raising EPS Estimates on Strong Specialty Outlook and Improving Order Book; Reiterating Sector Weight
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Specialty Chemicals Leading Indicators Through January 2019
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Destocking and Limited Visibility Prompts FY19 EPS Reduction; Specialty Demand Remains Solid
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
F4Q18 Adj. EPS of $0.17 Beats Consensus; Specialty Growth Momentum Continues
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Industry: Chemical - Specialty
Dire Wolf, the 4Q18 Was So Hard and Cold, Our Chemical Preview Still Sees Growth in 2019
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Industry: Chemical - Specialty
3Q18 Chemical Preview: Ripple - Will Headwinds or Positive Volume Prevail?
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Industry: Chemical - Specialty
Trimming EPS Outlook Following 3Q18 Results; Still See Growth on Upward Trajectory
Provider: KEYBANC CAPITAL MARKETS
Industry: Chemical - Specialty
Specialty Chemicals Leading Indicators Through August 2018
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Industry: Chemical - Specialty
F3Q18 Adj. EPS of $0.18 Misses Consensus; 2018 EPS Growth Outlook Maintained; Acquires Resiquimica, S.A
Provider: KEYBANC CAPITAL MARKETS
Analyst: SISON M
Industry: Chemical - Specialty
Research Summary
Provider: KEYBANC CAPITAL MARKETS